Literature DB >> 8130701

Reaching hidden populations of drug users by privileged access interviewers: methodological and practical issues.

P Griffiths1, M Gossop, B Powis, J Strang.   

Abstract

The methodological issues surrounding the use of a privileged access interviewer team to generate a network sample of drug users are examined. Traditionally network samples have tended to be used by qualitative researchers. Privileged access interviewing provides a mechanism for the application of a structured instrument to a network sampling model. In doing so some problematic issues in this area for structured methodology are overcome, reduced or standardized. The use of this method is appraised in terms of meeting the methodological requirements of the Drug Transitions study. The practical experiences of our group in using a privileged access interviewer team to interview more than 400 heroin users, many of whom were not in contact with treatment services, are discussed. This method is most appropriate for the quick collection of data, from diverse networks of drug users, by use of a structured instrument. Success is likely to be dependent on careful implementation. The ongoing monitoring of data quality is of particular importance, as is good management practice and the establishment of supportive and non exploitative relationships with the interviewer team.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8130701     DOI: 10.1111/j.1360-0443.1993.tb02036.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  36 in total

1.  Characteristics of heroin and cocaine users unknown to treatment agencies. Results from the Swiss Hidden Population Study.

Authors:  D Hausser; D Kübler; F Dubois-Arber
Journal:  Soz Praventivmed       Date:  1999

2.  Harnessing expertise: involving peer interviewers in qualitative research with hard-to-reach populations.

Authors:  Eva Elliott; Alison J Watson; Ursula Harries
Journal:  Health Expect       Date:  2002-06       Impact factor: 3.377

3.  Characteristics of high-risk HIV-positive IDUs in Vietnam: implications for future interventions.

Authors:  Vivian F Go; Constantine Frangakis; Le Van Nam; Teerada Sripaipan; Anna Bergenstrom; Fan Li; Carl Latkin; David D Celentano; Vu Minh Quan
Journal:  Subst Use Misuse       Date:  2010-08-24       Impact factor: 2.164

4.  Embarking on large-scale qualitative research: reaping the benefits of mixed methods in studying youth, clubs and drugs.

Authors:  Geoffrey Hunt; Molly Moloney; Adam Fazio
Journal:  Nordisk Alkohol Nark       Date:  2011-12-21

5.  Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study.

Authors:  Abu S Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Keith Sabin; Kathleen Gallagher; Don C Des Jarlais
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

6.  Effects of sex work on the prevalence of syphilis among injection drug users in 3 Russian cities.

Authors:  Lucy Platt; Tim Rhodes; Ali Judd; Evgeniya Koshkina; Svetlana Maksimova; Natalia Latishevskaya; Adrian Renton; Tamara McDonald; John V Parry
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

7.  Characteristics of Hidden Status Among Users of Crack, Powder Cocaine, and Heroin in Central Harlem.

Authors:  W Rees Davis; Bruce D Johnson; Hilary James Liberty; Doris D Randolph
Journal:  J Drug Issues       Date:  2004-12

8.  Evaluative criteria for qualitative research in health care: controversies and recommendations.

Authors:  Deborah J Cohen; Benjamin F Crabtree
Journal:  Ann Fam Med       Date:  2008 Jul-Aug       Impact factor: 5.166

9.  Un Jalón, Un Volteón, y Otra Vez: High-Risk Crack Smoking Paraphernalia in México City.

Authors:  Avelardo Valdez; Kathryn M Nowotny; Nalini Negi; Eduardo Zafra Mora; Alice Cepeda
Journal:  J Psychoactive Drugs       Date:  2016-06-29

10.  Emerging patterns of crack use in Mexico City.

Authors:  Avelardo Valdez; Charles Kaplan; Kathryn M Nowotny; Guillermina Natera-Rey; Alice Cepeda
Journal:  Int J Drug Policy       Date:  2015-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.